Lobbying Filing Details
Total Spending
$80,000
Activities
3
Lobbyists
9
Gov't Entities
6
Filing Information
- Filing UUID:
2fdac02a-ba81-4bdb-a621-28f26baa836b- Type:
- Q4 - 4th Quarter - Report
- Period:
- 2013 - 4th Quarter (Oct 1 - Dec 31)
- Date Posted:
- January 16, 2014 at 3:40 PM
- Income:
- $80,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Karina Lynch, Principal
Registrant
WILLIAMS AND JENSEN, PLLC
Lobbying Law Firm
Washington, District of ColumbiaClient
SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE
regenerative medicine company; develops and commercializes bioengineered tissue products
Connecticut, United States of AmericaLobbying Activities (3)
Activity 1
Health IssuesGeneral health care reform; CMS coding coverage issues. Issues related to attention deficit hyperactivity disorder (ADHD) medicines
Lobbyists (3)
- GEORGE OLSEN
- KARINA LYNCH
- MR. DAVID A STARR
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Medicare/MedicaidCMS bundling rules for the hospital outpatient prospective payment system. ACA implementation. Rebates for Medicare Part D.
House and Senate action on H.J. Res. 59 and possible drug industry issues. The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013
Lobbyists (6)
- JENNY DIJAMES
- GEORGE OLSEN
- KARINA LYNCH
- MS. MELINDA M MAXFIELD
- MR. MATTHEW B HOEKSTRA
- ERIN BOOK MULLEN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue CodeTax issues affecting the pharmaceutical industry. Casey SGR amendment.
Lobbyists (4)
- BERTRAM CARP
- GEORGE OLSEN
- KARINA LYNCH
- MR. CHRISTOPHER W HATCHER
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES